CHRS
Coherus BioSciences Inc
1.20$
-7.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.9% | 92.4% | 62.3% | 45.5% | 29.3% | 62.5% | 48.7% | 43.0% | 40.5% | 38.8% | 38.1% | 29.6% | 36.4% | |
| 56.1% | 7.6% | 37.7% | 54.5% | 70.7% | 37.5% | 51.3% | 57.0% | 59.5% | 61.2% | 61.9% | 70.4% | 63.6% | |
| 34.4% | 28.8% | 1,231.5% | 32.0% | 30.6% | 39.2% | 306.8% | 246.6% | 227.2% | 235.9% | 167.8% | 149.9% | 193.3% | |
| 64.7% | 40.1% | 2,449.4% | 54.1% | 49.1% | 43.8% | 342.5% | 253.9% | 215.5% | 185.2% | 187.7% | 146.5% | 181.8% | |
| 99.1% | 82.9% | 2,974.7% | 86.1% | 79.7% | 115.5% | 649.2% | 500.6% | 424.5% | 421.1% | 355.5% | 296.3% | 371.0% | |
| -42.9% | -75.3% | -2,937.0% | -31.6% | -9.0% | -78.0% | -597.9% | -443.6% | -365.0% | -359.9% | -293.7% | -226.0% | -307.4% | |
| 13.8% | 11.6% | 481.6% | 8.2% | 7.6% | 9.9% | 28.3% | 22.2% | 20.1% | 17.6% | 17.8% | 16.2% | 17.8% | |
| -53.7% | -87.0% | -2,947.8% | -19.9% | -15.2% | -93.6% | -623.7% | -437.5% | -384.7% | -363.6% | -300.0% | -233.1% | -316.4% | |
| -0.5% | -11.6% | 63.4% | – | – | -93.6% | 120.7% | -3,341.4% | -77.7% | -68.3% | 11.3% | -88.9% | -57.0% | |
| -53.2% | -87.0% | 4,457.3% | -19.9% | -15.2% | -93.6% | -744.4% | -403.1% | -303.4% | -292.4% | -308.2% | -144.2% | -257.1% | |
| -37.7% | -74.3% | -2,747.4% | -9.8% | -5.4% | -81.9% | -581.7% | -405.4% | -356.3% | -338.9% | -275.1% | -210.8% | -291.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.